July 22, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

Some hospitals failing to comply with the federal price transparency regulation have been fined. The website of CMS.gov lists 15 hospitals and the amount each was fined. On June 6, 2022, the first fines were levied against Northside Hospital of Atlanta ($883,130) and Northsid…

Read More

---

July 1, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

Last week, it was announced that Quest Diagnostics “would acquire select laboratory assets from 12-hospital Allina Health” the Minneapolis-based health sys­tem. Quest stated, “Under the terms of the definitive agree­men…

Read More

---

May 20, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 7 – May 20, 2024 Issue

Last month, members of a class action lawsuit against Theranos and other defendants received settlement checks. Members of the class included TDR’s Editor-in-Chief, Robert Michel, and his wife, Deborah. On behalf of The Dark Report, the Michels had investigated the actual laborator…

Read More

---

August 21, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 12 – August 21, 2023 Issue

New research about ownership of physician practices will be of interest to anatomic pathologists who operate their own businesses. According to an analysis by the American Medical Association (AMA),…

Read More

---

July 31, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 11 – July 31, 2023 Issue

Regulatory relief is on the way for clinical laboratories accredited by The Joint Commission. An overhaul of the Laboratory Accreditation Program’s standards, which goes into effect Aug. 27, will …

Read More

---

QuidelOrtho Earns $3.3 Billion in First Year as Combined Firm

By Robert Michel | From the Volume XXX No. 4 – March 6, 2023 Issue

IN OUR FEBRUARY 13, 2023, ISSUE OF THE DARK REPORT, we analyzed the 2022 full-year and Q4 earnings of major IVD companies. At the time our prior issue went to press, QuidelOrtho had not yet reported its year-end results.  …

Read More

---

2022’s Top 10 Lab Stories Confirm Challenging Times

By Scott Wallask | From the Volume XXIX, No. 17 – December 12, 2022 Issue

CEO SUMMARY: There are valuable insights to be gleaned from The Dark Report’s “Top 10 Lab Industry Stories for 2022.” Several of this year’s story picks involve external forces reshaping healthcare in the United States in profound ways. Other story picks for 2022 illustrate …

Read More

---

Reports Say Qiagen and Bio-Rad Discussing Potential IVD Merger

By Scott Wallask | From the Volume XXIX, No. 15 – October 31, 2022 Issue

More consolidation in the in vitro diagnostics (IVD) mar­ket may soon happen. Bio-Rad Laboratories and Qiagen are reportedly in merger discussions. The Wall Street Journal, which broke the story on Oct. 10, tabbed the potential deal as being worth …

Read More

---

October 10, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 14 – October 10, 2022 Issue

Future regulation of laboratory-developed tests (LDTs) may not be as clear as it once appeared. On Sept. 30, Congress passed a short-term resolution to keep the federal government funded. As part of the move, a proposed bill to increase oversight of LDTs has been sidelined, at least for now, accordin…

Read More

---

Lean Is Smart Approach to Major Lab Cost Savings

By Robert Michel | From the Volume XXIX, No. 13 – September 19, 2022 Issue

CEO SUMMARY: It’s a time when clinical labs are under extreme pressure to cut costs, even as they deal with understaffing. One proven approach to reducing expenses while preserving quality is to apply Lean methods in conjunction with Six Sigma tools. It is often true that successf…

Read More

---